SRL
PFE icon

Scientech Research LLC’s Pfizer PFE Stock Holding History

Scientech Research LLC’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,871
Closed -$506K – 732
2025
Q3 		$506K Buy
+19,871
New +$490K 0.18% 256
2024
Q4 		– Sell
-12,483
Closed -$361K – 795
2024
Q3 		$361K Buy
+12,483
New +$364K 0.07% 448
2024
Q2 		– Sell
-11,332
Closed -$314K – 706
2024
Q1 		$314K Buy
+11,332
New +$314K 0.17% 275

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Scientech Research LLC's PFE Position: Q4 2025 in Review

Scientech Research LLC sold out of Pfizer (PFE) in Q4 2025, closing a stake of 19,871 shares — an estimated $506K sold.

Scientech Research LLC first reported a position in PFE in Q1 2024 and held it in 3 quarters. The position peaked at $506K in Q3 2025. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Scientech Research LLC reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Scientech Research LLC sold 19,871 Pfizer shares in Q4 2025, an estimated $506K.
  • Scientech Research LLC first reported a position in Pfizer in Q1 2024 and held it in 3 quarters.
  • Scientech Research LLC's Pfizer position peaked at $506K in Q3 2025.
  • 2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Scientech Research LLC's 13F filing for Q4 2025, filed 17 Feb 2026.